ECP 2018 Final Programme

Monday, 10 Sept 98 ECP 2018 · Bilbao Poster Presentations a Monday PS-12 028 The prognostic value of tumour budding in lung squamous cell carcinoma Merih Tepeoglu, Turkey G. Özgun, D. Kilic, B. H. Ozdemir 029 Histological transformation as resistance mechanism of the treatment with EGFR inhibitors in lung adenocarcinoma. Two cases report Manuela Vazquez Peraita, Spain C. Romero Abrio, A. Zumarraga, J. C. Lopez, R. Zaballa, A. Ugalde, N. Arbide, E. Fuertes, M. C. Etxezarraga 030 Investigation of lung squamous cell carcinoma in multiple squamous cell carcinoma cases Tokiko Nakai, Japan H. Itami, K. Morita, A. Okada, N. Kawai, C. Ohbayashi 031 Three cases in a family of hereditary interstitial lung disease with COPA gene mutation Yoshiro Otsuki, Japan Y. Arai, K. Mizukami, H. Kobayashi 032 Primary pulmonary salivary gland-type tumours: a single-institute experience with a focus on the histologic types and clinical outcome Dalma Udovicic-Gagula, Bosnia and Herzegovina N. Bilalovic 033 Association between pd-l1 expression and driver mutations in non-small-cell lung cancer patients in a specific region Ihab Abdulkader Nallib, Spain S. M. Garcia Acuña, F. J. Caneiro Gomez, D. C. Insua Santamaria, M. Piso-Neira, H. Lazare Iglesias, J. R. Antunez Lopez, J. M. Cameselle-Teijeiro, M. Sanchez Ares 034 Micro-RNA 215 and 375 regulate thymidylate synthase protein expression in MPM patients Francesca Napoli, Italy I. Rapa, S. Izzo, P. Bironzo, S. Novello, G. Scagliotti, M. Volante, M. Papotti, L. Righi Best Poster Sessions The best posters of each topic will be presented during the afternoon coffee break (16:45–17:15 Sunday– Tuesday, 13:15–13:45 Wednesday) at the E-Poster terminals in Exhibition Hall I / II. i